Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. (2021)
Attributed to:
Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE)
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2213-2600(21)00310-6
PubMed Identifier: 34329624
Publication URI: http://europepmc.org/abstract/MED/34329624
Type: Journal Article/Review
Volume: 9
Parent Publication: The Lancet. Respiratory medicine
Issue: 9
ISSN: 2213-2600